Arthneeti
Latest: TruAlt Bioenergy Q2 FY27 (Jul–Sep 2026) results →This page is Q1 FY27 (Apr–Jun 2026).All Q1 FY27 results →
TB

TruAlt Bioenergy

Q1 FY27Agricultural Food & other Products

TruAlt Bioenergy Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹438
Market cap₹3.8K Cr
P/E24.5
Updated25 Aug 2026
Read4 min read

TruAlt Bioenergy Q1 FY27 key numbers

Revenue
The company has 44 crore litres of ethanol orders on hand for FY27, expecting volumes higher than last year's 40 crore litres.

As stated in TruAlt Bioenergy's Q1 FY27 earnings call transcript · published 25 Aug 2026. Reported figures, not investment advice.

The short version

TruAlt Bioenergy expects to increase ethanol capacity utilization from current ~60% to 80-90% in upcoming quarters, with Q2 FY27 sales projected at around 11 crore litres (Page 22). The company expects to increase ethanol production and improve capacity utilization from the current 60% to around 80-90%, which should boost revenues and profits in upcoming quarters.

From TruAlt Bioenergy's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

  • TruAlt Bioenergy expects to increase ethanol capacity utilization from current ~60% to 80-90% in upcoming quarters, with Q2 FY27 sales projected at around 11 crore litres (Page 22).
  • The company has 44 crore litres of ethanol orders on hand for FY27, expecting volumes higher than last year's 40 crore litres (Page 8).
  • No further capex planned in ethanol segment; focus on utilizing existing capacity fully (Page 7).
  • CBG revenues to begin from Q4 FY27 with ongoing capex of ~INR700 crores, expanding compressed biogas business (Page 7).
  • SAF (Sustainable Aviation Fuel) business involves a planned INR2,000 crore capex with revenues anticipated starting FY29, expected asset turnover of 1x (Page 7).

2 more points from TruAlt Bioenergy's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what TruAlt Bioenergy said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • No further capex planned in the ethanol segment as all capacities are commissioned and ready for utilization.
  • INR ~700 crores capex underway in the CBG segment through two JVs:
  • INR 330 crores for four 20 TPD CBG plants with Sumitomo.
  • INR 425 crores for six 10 TPD CBG plants with GAIL.
  • CBG capex funded at 70:30 debt-to-equity; TruAlt holds 51% stake.
  • INR ~2,000 crores capex planned for Sustainable Aviation Fuel (SAF) production, with EPC contract awards awaited.
  • SAF capex expected to start within 2-3 months, with revenues anticipated by FY29 (end 2028).

2 more points from TruAlt Bioenergy's call on capex

Create a free account to keep reading this call

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

Guidance-ranked
1Regaal Resources
Rev 1Mar 2
2TBI Corn
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what TruAlt Bioenergy said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • TruAlt Bioenergy currently has an order book of approximately 44 crore litres of ethanol for FY2027.
  • This includes orders from Oil Marketing Companies (OMCs), private sector, and ENA sales.
  • In Q1 FY27, they sold about 8.29 crore litres and expect around 11 crore litres of sales in Q2 FY27, indicating a strong pipeline.
  • There is an ongoing 15 crore litre spillover order from the previous period, currently under discussions with OMCs, expected to be realized soon.

2 more points from TruAlt Bioenergy's call on order book

Create a free account to keep reading this call

TruAlt Bioenergy — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹811 Cr, net profit ₹35 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What TruAlt Bioenergy's management said in earlier quarters

Others in Agricultural Food & other Products this season

  • Sayaji Industr (Q1 FY27)

    Revenue from Operations for Q1FY27: ₹288 crore . Key investor presentation takeaways from Sayaji Industries Ltd's Q1 FY27 investor presentation — and how it ran

  • Sanstar (Q1 FY27)

    2,062 million, up 21.5% YoY from Rs. Key investor presentation takeaways from Sanstar Ltd's Q1 FY27 investor presentation — and how it ranks against sector peer

  • Uttam Sug.Mills (Q1 FY27)

    588.46 Cr vs Rs. Key investor presentation takeaways from Uttam Sugar Mills Ltd's Q1 FY27 investor presentation — and how it ranks against sector peers.

  • NFP Sampoorna (Q1 FY27)

    FY26 revenue grew 43% to INR 51 crore from INR 35 crore in FY25, driven by better capacity utilization and portfolio diversification. Key concall takeaways…

Compare:vs Maricovs Tata Consumervs Patanjali Foods

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

TruAlt Bioenergy and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were TruAlt Bioenergy Q1 FY27 results?

TruAlt Bioenergy expects to increase ethanol capacity utilization from current ~60% to 80-90% in upcoming quarters, with Q2 FY27 sales projected at around 11 crore litres (Page 22). The company expects to increase ethanol production and improve capacity utilization from the current 60% to around 80-90%, which should boost revenues and profits in upcoming quarters.

What is TruAlt Bioenergy share price analysis?

TruAlt Bioenergy currently shows a neutral. The stock trades at a P/E of 24.5 with a market cap of ₹3,826 Cr. Investors should review the full earnings analysis for detailed insights.

Is TruAlt Bioenergy planning capital expenditure?

No further capex planned in the ethanol segment as all capacities are commissioned and ready for utilization.

Keep TruAlt Bioenergy on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.